Labcorp Holdings Inc. (FRA:N6B)

Market Cap	20.73B
Revenue (ttm)	11.48B
Net Income (ttm)	650.04M
Shares Out	n/a
EPS (ttm)	7.72
PE Ratio	31.89
Forward PE	17.16
Dividend	2.63 (1.11%)
Ex-Dividend Date	Aug 28, 2025

Volume	51
Average Volume	3
Open	238.00
Previous Close	236.00
Day's Range	238.00 - 238.00
52-Week Range	183.00 - 242.00
Beta	n/a
RSI	64.46
Earnings Date	Oct 23, 2025

About Labcorp Holdings

Labcorp Holdings Inc. provides laboratory services. It operates through two segments, Diagnostics Laboratories and Biopharma Laboratory Services. The company offers various tests, such as blood chemistry analyses, urinalyses, blood cell counts, thyroid, PAP, hemoglobin A1C, prostate-specific antigens, sexually transmitted diseases, hepatitis C, vitamin D, microbiology cultures and procedures, and alcohol and other substance-abuse tests. It also provides specialty testing services comprising gene-based and esoteric testing; advanced tests target...

• Industry: Medical Laboratories
• Founded: 1995
• Employees: 70,000
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: N6B

Financial Performance

In 2024, Labcorp Holdings's revenue was $13.01 billion, an increase of 6.97% compared to the previous year's $12.16 billion. Earnings were $746.00 million, an increase of 78.47%.

Financial numbers in USD